Gsa Capital Partners LLP Cytosorbents Corp Transaction History

Gsa Capital Partners LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$1.76 - $3.22 $231,712 - $423,929	-131,655 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$2.88 - $4.23 $341,717 - $501,897	118,652 Added 912.5%	131,655 $420,000
Q4 2021 Feb 14, 2022	BUY	$4.05 - $8.11 $52,662 - $105,454	13,003 New	13,003 $54,000
Q2 2020 Aug 11, 2020	SELL	$6.28 - $10.59 $476,457 - $803,452	-75,869 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$3.77 - $7.73 $41,089 - $84,249	10,899 Added 16.78%	75,869 $586,000

Q4 2019 Feb 12, 2020	BUY	$3.61 - $5.22 $116,061 - $167,823	32,150 Added 97.96%	64,970 $250,000
Q3 2019 Nov 12, 2019	BUY	$4.33 - $7.63 $142,110 - $250,416	32,820 New	32,820 $165,000
Q2 2019 Aug 06, 2019	SELL	$5.92 - $7.78 $99,941 - $131,341	-16,882 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$6.82 - $8.56 $115,135 - $144,509	16,882 New	16,882 $128,000

17.8M

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $39.7M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.